AzTrials
AzTrials

ResuscitationPhase 4CARENCT00631098

Cannulation for Resuscitation

A Phase 4 study testing venous cannulation in people with Resuscitation, run by Kuopio University Hospital at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

International CPR guidelines recommend the cannulation of a peripheral vein (antecubital or external jugular) during resuscitation. One reason for preferring the external jugular vein over more peripheral veins is the faster circulation time of drugs during CPR. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Resuscitation
What is being tested?
venous cannulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFinland
Study dates
Mar 2004to Dec 2008
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Cardiac surgery patients

Who cannot join

  • Morbid obesity (BMIover 35)
  • Severe cardiac insufficiency (ejection fraction below 30%)

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Department of Anesthesiology and Intensive Care/ Kuopio University hospital

    Kuopio, 70211

Other trials in Finland

About this study

Official title: The Feasibility of Cannulating External Jugular Vein Compared With Cubital Vein (by Paramedics and Emergency Department Interns)

International CPR guidelines recommend the cannulation of a peripheral vein (antecubital or external jugular) during resuscitation. One reason for preferring the external jugular vein over more peripheral veins is the faster circulation time of drugs during CPR. The differences in circulation time may be over 90 seconds between peripheral and central (internal jugular) veins. However, cannulation of the external jugular vein may be more difficult and time consuming than cannulating cubital veins. There are no studies on the success rate, cannulation time and reliability of venous access comparing central and peripheral cannulation sites.

We hypothesized that cannulation of the external jugular vein (by paramedics and is a demanding procedure in an emergency situation and should not be recommended during resuscitation.

The aims of this study are to compare the feasibility of cannulating the external jugular vein compared to the cubital vein in terms of attempts, cannulation time and reliability of venous access.

Read the detailed description

The protocol includes measurement of:

  1. The time of cannulation
  2. Number of attempts of cannulation, Every piercing of skin is counted as one attempt. Maximally three attempts will be allowed.
  3. Failures. Perforation of vein and subcutaneous hemorrhage, arterial puncture, the appropriate vein is not found, free back flow of blood or free infusion of saline is not achieved the attempt are considered as failures . Cannulation of another site is then started or the study is ended.

The final protocol of the study will be a paired control, randomized prospective study. The randomization will be for the order of cannulation site (internal jugular or cubital vein first) In the final study the cannulation will be performed by emergency department interns and paramedics with advanced cardiac life support skills and licenced by Kuopio University Hospital.

For comparison and describing the experience of the paramedics an enquiry is accomplished and the following data are collected:

  1. Age
  2. Experience as a paramedic (years after graduation)
  3. Theoretical guidance of cannulation (self estimated /hours)
  4. Practical guidance of cannulation (self estimated/hours)
  5. Experience of cannulation of the external jugular vein (self estimated/times)

For comparison and describing the experience of the interns in the ER a similar enquiry is accomplished,:

  1. Age
  2. Experience as an intern (years after graduation as MD)
  3. Theoretical guidance of cannulation (self estimated /hours)
  4. Practical guidance of cannulation (self estimated/hours)
  5. Cannulation of external jugular vein (self estimated/times) Statistical analysis

The primary endpoint in this study is cannulation time of the two sites (internal jugular and cubital vein). The secondary end points are failure/success of cannulation and reliability of venous access as defined above.

Patient characteristics and anesthetic and operative variables are compared with the t-test for independent samples (continuous variables), or the Mann-Whitney U-test and 2-test (Pearson) or Fishers exact test when appropriate (categorical variables). Cannulation time differences between the groups will be compared with the t-test for independent samples (after tests for homoscedasticity and normality) or Mann-Whitney U-test if appropriate. Success of cannulation will be compared with 2-test (Pearson) or Fishers exact test when appropriate. A p value less than 0.05 is considered statistically significant. Results are given as mean (SD) or number of patients. All statistical analyses will be performed with SPSS version 11.01 software (SPSS Inc, Chicago, IL, USA).

Conditions
Resuscitation
Being tested
venous cannulation
Keywords
Resuscitation, venous cannulation, external jugular vein, cubital vein

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • venous cannulationProcedure or surgery

    External jugular and cubital vein cannulation

Study groups in NCT00631098
Study groupRoleWhat they receive
1ExperimentalCannulation of external jugular vein and cannulation of cubital vein
Receives: Procedure: venous cannulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome measure in this study is cannulation time of the two sites (internal jugular and cubital vein).

    Measured: Cannulation time (minutes)

Secondary outcomes (1)
  1. The secondary end points are failure/success of cannulation and reliability of venous access.

    Measured: success of cannulation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2008 (estimated)
  2. Study startMar 2004
  3. Primary completionDec 2008
  4. Study completionDec 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00631098
Sponsor's protocol ID
KUH5070198
Acronym
CARE
Status last verified
Jan 2009
First submitted
27 Feb 2008
Last updated
21 Jan 2009
Results posted
No
Data monitoring committee
No

Publications

  • Lahtinen P, Musialowicz T, Hyppola H, Kiviniemi V, Kurola J. Is external jugular vein cannulation feasible in emergency care? A randomised study in open heart surgery patients. Resuscitation. 2009 Dec;80(12):1361-4. doi: 10.1016/j.resuscitation.2009.08.026. Epub 2009 Oct 4.

    PubMed 19804930

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing venous cannulation in people with Resuscitation, run by Kuopio University Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jan 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome measure in this study is cannulation time of the two sites (internal jugular and cubital vein). (time frame: Cannulation time (minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00631098, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in